Abstract
This work addresses the kinetic analysis of the interaction of methotrexate (MTX) with human erythrocyte membrane-bound acetylcholinesterase (AChE, EC 3.1. 1.7). It was found that the MTX effect was independent of time of incubation with AChE before the addition of substrate which proves its reversible action. The IC50 was determined, by three methods, to be 0.73 mM. The Michaelis-Menten constant (Ks) for the hydrolysis of acetylthiocholine iodide (ASCh) by AChE was 0.13 mM in the control system, a value decreased by 30–61% in the MTX treated systems. The Vmax was 1.27μtmole/min/mg protein for the control system while it was decreased by 44–77% in the MTX treated systems. The Linexveaver-Buck plot, Dixon plot, and their secondary replots indicated that the nature of the inhibition was of the linear mixed type, i.e. uncompetitive and noncompetitive. The values of Ki(slope) and KI(tntecept) were estimated as 1.67 and 0.34 mM, respectively.
Similar content being viewed by others
Abbreviations
- AChE:
-
acetylcholinesterase
- ASCh:
-
acetylthiocholine
- Ks :
-
Michaelis-Menten constant
- Vmax :
-
the limiting maximal velocity
- Ki :
-
inhibition constant
- MTX:
-
methotrexate
References
Bertino JR: Toward improved selectivity in cancer chemotherapy: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 39: 293–304, 1979
Avella M, Bacci G, Mcdonald DJ, Discioscio M, Picci P, Campanacci M: Adjuvant chemotherapy with six drugs (adriamycin, methotrexate, cisplatinum, bleomycin, cyclophosphamide and dactinomycin) for non-metastatic, high-grade osteosarcoma of the extremities. Chemioterapia 7: 133–137, 1988
Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE: Efficacy of low-dose methotrexate in rheumatoid arthritis. New Engl J Med 312: 818–822, 1985
Rees RB, Bennt JR, Maibach HI, Arnold HL: Methotrexate for psoriasis. Arch Dermatol 95(1): 2–11, 1967
Allen JC, Rosen G: Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma. Ann Neurol 3: 441–444, 1978
Haddara MA, El-Badawi MG, Fatani JA., Ibrahim M, Dahaha NM: Neuronal death after I.P. injection of methotrexate in young mice. AlAzher Med J 14: 25–30, 1985
El-Badawi MG, Fatani JA, Qayyum MA: Methotrexate neurotoxicitya histochemical study. Anat Anz 164: 47–52, 1987
Schornagel JH, McVie JG: The clinical pharmacology of methotrexate. Cancer Treat Revs 10: 53–75, 1983
Dahl MGC, Gregory MM, Schenrer PJ: Liver damage due to methotrexate in patient with psoriasis. Br Med J 1: 625–630, 1971
Leblanc GA, Waxman DJ: Interaction of anticancer drugs with hepatic monooxgenase. Drug Meta Rev 20(2–4): 395–439, 1989
Sadzuka Y, Shoji T, Takino Y: Effect of cisplatin on the activites of enzymes which protect against lipid peroxidation. Biochem Pharmacol 43: 1872–1875, 1992
Al-Jafari AA: The toxicological effect of cyclophosphamide on acetylcholinesterase activity. Toxicol Lett 66: 125–131, 1993
Al-Jafari AA, Duhaiman AS, Kamal MA: Inhibition of human acetylcholinesterase by cyclophosphamide. Toxicology 96 (1): 1–6, 1995
Al-Jafari AA, Kamal MA, Duhaiman AS: The mode of inhibition of human erythrocyte membrane bound acetylcholinesterase by cisplatin in vitro. J Enzyme Inhib 8: 281–289, 1995
Qayyum MA, Fatalii JA, El-Badawi MG: Partial degeneration of autonomic nerves of the heart of methotrexate-treated guinea pigs. Acta Anat 131: 52–55, 1988
Rosenbery TL: Quantitative simulation of endplate currents at neuromuscular junction based on the reaction of acetylcholine with acetylcholin receptor and acetylcholinesterase. Biophys J 26: 263–290, 1979
Sorensen K, Gentinetta R, Brodbeck U: An amphiphile-dependent form of human brain caudate nucleus acetylcholinesterase: Purification and properties. J Neurochem 39: 1050–1060, 1982
Al-Jafari AA: Investigation of the reversible inhibition of camel (camelus dromedarius) acetylcholinesterase by tetracaine. Comp Biochem Physiol 105: 323–327, 1993
Ellman GL, Courtney D, Andres V, Featherston, RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88–95, 1961
Lowry OH, Rosebrough NJ, Farr AL, Randall, RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275, 1953
Al-Jafari AA, Kamal MA: The preparation and kinetic properties of multiple forms of chicken brain acetylcholinesterase. Cell Biochem Funct 12: 29–35, 1994
Daniel WW: A foundation for analysis in the Health Sciences Biostatistics. John Wiley, New York, 1991, pp 424–438
Eisenthal R, Danson MJ: Enzyme assays: A practical approach. Oxford University press Inc., New York, 1993, pp 312–313
Segel IH: Enzyme kinetics: Behaviour and analysis of rapid equilibrium and steady-state enzyme systems. John Wiley and Sons, New York, 1975, pp 170–176
Dixon M: The determination of enzyme inhibitor constants. Biochem 155: 170–171, 1953
Butterworth PJ: The use of Dixon plots of study enzyme inhibition. Biochim Biophys Acta 289: 251–256, 1972
Dawson R: Reversibility of the inhibition of acetylcholinesterase by tacrine. Neurosci. Lett 11: 85–87, 1990
Segel IH: Enzyme kinetics: Behaviour and analysis of rapid equilibrium and steady-state enzyme systems. John Wiley and Sons, New York, 1975, p 188
Segel IH: Enzyme kinetics: Behaviour and analysis of rapid equilibrium and steady-state enzyme systems. John Wiley and Sons, New York, 1975, p 109
Goldenberg GJ, Vanstone CL, Bihler I: Transport of nitrogen mustard on the transport- carrier for choline in L5178Y Lymphoblasts. Science 172: 1148–1149, 1971
Cohen SG, Chishti SB, Bell DA, Howard SL, Salih E, Cohen JB: General occurrence of binding to acetylcholinesterase-substrate complex in noncompetitive inhibition and in inhibition by substrate. Biochem Biophys Acta 1076: 112–122, 1991
Hallak M, Szinicz L: Effects of some mono-and bisquaternary ammonium compounds on the reactivatability of soman-inhibited human acetylcholinesterase in vitro. Biochem Pharmacol 37: 819–825, 1988
Al-Jafari AA: The effect of tetrabutylammonium ion on chicken brain acetylcholinesterase activity in vitro. Drug Chem Toxicol 15 (4): 295–312, 1992
Al-Jafari AA: The inhibitory effect of tetrarnethylethylene diamine on water soluble and membrane bound acetylcholinesterase activity. Int J Biochem 25(3): 319–324, 1993
Patterson TA, Terry AV, Kosh JW: Prevention of physostigmine-, DFP-, and diazinon-induced acute toxicity by monoethylcholine and N-aminodeanol. Br J Pharmacol 97: 451–460, 1989
Okonek S, Kilbinger H: Determination of acetylcholine, nitrostigmine, and acetylcholinesterase activity in four patients with severe nitrostigmine (E 605 forte) intoxication. Arch Toxicol 32: 97–108, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kamal, M.A., Nasim, F.H. & Al-Jafari, A.A. In vitro inhibition of human erythrocyte acetylcholinesterase (EC3.1.1.7) by an antineoplastic drug methotrexate. Mol Cell Biochem 159, 47–53 (1996). https://doi.org/10.1007/BF00226062
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00226062